Advertisement
Research
Rivaroxaban is a direct oral anticoagulant designed to dispense with the necessity of laboratory monitoring. However, monitoring rivaroxaban levels is necessary in certain clinical conditions, especially in th...
Thrombosis Journal 2017 15:21
Published on: 15 August 2017
Case report
Paget-Schrotter Syndrome (PSS) also known as “effort thrombosis” is a form of primary thrombosis in the subclavian vein at the costoclavicular junction is usually seen in younger patients after repeated strenu...
Thrombosis Journal 2017 15:20
Published on: 1 August 2017
Research
Patient awareness of venous thromboembolism (VTE) and thromboprophylaxis is essential for their safety. In this study, we evaluated patients’ awareness of VTE and their perceptions of thromboprophylaxis.
Thrombosis Journal 2017 15:19
Published on: 19 July 2017
Case report
Evans syndrome (ES) is a rare disease characterized by simultaneous or sequential development of autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP) with or without immune neutropenia. Splenec...
Thrombosis Journal 2017 15:18
Published on: 3 July 2017
Letter to the Editor
As proposed diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis has been approved and revised, the contents and changes are informed.
Thrombosis Journal 2017 15:17
Published on: 3 July 2017
Research
Orthostatic hypercoagulability is proposed as a mechanism promoting cardiovascular and thromboembolic events after awakening and during prolonged orthostasis.
Thrombosis Journal 2017 15:16
Published on: 20 June 2017
Research
The effects of Ramadan fasting (RF) on clopidogrel antiplatelet inhibition were not previously investigated. The present study evaluated the influence of RF on platelet reactivity in patients with high cardiov...
Thrombosis Journal 2017 15:15
Published on: 2 June 2017
Review
Direct oral anticoagulants (DOACs) have been licensed worldwide for several years for various indications. Each year, 10–15% of patients on oral anticoagulants will undergo an invasive procedure and expert gro...
Thrombosis Journal 2017 15:14
Published on: 15 May 2017
Review
Recently, the European Medicines Agency (EMA) authorized the introduction and marketing of Thorinane® and Inhixa®, biosimilars of the Low Molecular Weight Heparin (LMWH) enoxaparin. The authorization path is c...
Thrombosis Journal 2017 15:13
Published on: 10 May 2017
Review
Patients with reduced cardiac function are thought to have a higher risk of venous thromboembolism (VTE). Additionally, they are vulnerable to complications of pulmonary embolism (PE) as well as right heart fa...
Thrombosis Journal 2017 15:12
Published on: 24 April 2017
Research
The transmembrane receptor molecule CD31 is known to have immunomodulatory functions, suggesting a possible neuroprotective effect in the context of acute ischemic stroke by restricting an over-activation of s...
Thrombosis Journal 2017 15:11
Published on: 13 April 2017
Case report
Saphenous vein graft thrombosis can present as unstable angina. However, percutaneous coronary intervention for saphenous vein graft lesions poses a high risk of slow flow related to the procedure. Here we pre...
Thrombosis Journal 2017 15:10
Published on: 4 April 2017
Research
Blood coagulation plays a crucial role in the blastocyst implantation process and its alteration may be related to in vitro fertilization (IVF) failure. We conducted a prospective observational longitudinal st...
Thrombosis Journal 2017 15:9
Published on: 28 March 2017
Case report
Because the venous thromboembolisms (VTEs) due to the coagulation factor V R506Q (FV Leiden) mutation is often seen in Caucasians, the VTE onset in Japan has not been reported.
Thrombosis Journal 2017 15:8
Published on: 14 March 2017
Review
Small interfering (si) RNAs and antisense oligonucleotides (ASOs; here for simplicity reasons, both referred to as oligonucleotides) are small synthetic RNA or DNA molecules with a sequence complementary to a ...
Thrombosis Journal 2017 15:7
Published on: 7 March 2017
Research
An increasing number of patients are treated with direct-acting oral anticoagulants (DOACs), but the optimal way to reverse the anticoagulant effect is not known. Specific antidotes are not available and proth...
Thrombosis Journal 2017 15:6
Published on: 20 February 2017
Research
Platelets from untreated periodontitis patients are hyper-reactive and form more platelet-leukocyte complexes compared to cells from individuals without periodontitis. It is not known whether the improvement o...
Thrombosis Journal 2017 15:5
Published on: 6 February 2017
Case report
Although vein stenting is popular for treatment for venous thromboembolism due to mechanical compression, some cases are forced to avoid inserting align agents because of immunodeficiency.
Thrombosis Journal 2017 15:4
Published on: 1 February 2017
Research
Strenuous exercise may trigger myocardial infarction through increased pro-coagulant activity. We aimed to investigate whether patients referred for exercise testing, who were found to have angiographically ve...
Thrombosis Journal 2017 15:3
Published on: 19 January 2017
Research
Patients undergoing major abdominal surgery are at high risk for developing venous thromboembolism in the post-operative period. Current evidence-based guidelines recommend routine pharmacological venous throm...
Thrombosis Journal 2017 15:2
Published on: 13 January 2017
Research
Genome-wide association study (GWAS) has reported that rs6903956 within the first intron of androgen-dependent tissue factor pathway inhibitor (TFPI) regulating protein (ADTRP) gene is associated with coronary ar...
Thrombosis Journal 2017 15:1
Published on: 7 January 2017
Review
Ensuring quality has become a daily requirement in laboratories. In haemostasis, even more than in other disciplines of biology, quality is determined by a pre-analytical step that encompasses all procedures, ...
Thrombosis Journal 2016 14:49
Published on: 12 December 2016
Review
It has become widely recognised that outpatient treatment may be suitable for many patients with venous thromboembolism. In addition, non-vitamin K antagonist oral anticoagulants that have been approved over t...
Thrombosis Journal 2016 14:47
Published on: 5 December 2016
Research
The objective of this analysis was to assess the effects of edoxaban compared with enoxaparin on key coagulation biomarkers and present pooled primary efficacy and safety results from phase 3 STARS E-3 and STA...
Thrombosis Journal 2016 14:48
Published on: 1 December 2016
Research
Thrombolytic therapy is effective in selected patients with deep vein thrombosis (DVT). Therefore, identification of a marker that reflects the age of thrombus is of particular concern. This pilot study aimed ...
Thrombosis Journal 2016 14:46
Published on: 22 November 2016
Advertisement
